Omega-3 Fatty Acids Not Found to Up Risk of Heart Disease

Share this content:
Omega-3 Fatty Acids Not Found to Up Risk of Heart Disease
Omega-3 Fatty Acids Not Found to Up Risk of Heart Disease

THURSDAY, Feb. 1, 2018 (HealthDay News) -- Supplementation with omega-3 fatty acids is not associated with fatal or nonfatal coronary heart disease or major vascular events, according to a review published online Jan. 31 in JAMA Cardiology.

Theingi Aung, M.B.B.S., from the University of Oxford in the United Kingdom, and colleagues conducted a meta-analysis of all large trials assessing the correlation of omega-3 fatty acid supplements with the risk of fatal and nonfatal coronary heart disease and major vascular events. Study-level data were obtained from 10 large randomized clinical trials with a total of 77,917 high-risk individuals; the trials lasted a mean of 4.4 years.

The researchers found that there was no correlation for randomization to omega-3 fatty acid supplementation with coronary heart disease death (rate ratio, 0.93; 99 percent confidence interval, 0.83 to 1.03; P = 0.05), nonfatal myocardial infarction (rate ratio, 0.97; 99 percent confidence interval, 0.87 to 1.08; P = 0.43), or any coronary heart disease events (rate ratio, 0.96; 95 percent confidence interval, 0.9 to 1.01; P = 0.12). Randomization to omega-3 fatty acid supplementation also had no significant associations with major vascular events (rate ratio, 0.97; 95 percent confidence interval, 0.93 to 1.1; P = 0.1) overall or in any subgroups.

This meta-analysis "provides no support for current recommendations for the use of such supplements in people with a history of coronary heart disease," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Enrollment Under the Affordable Care Act Down From Last Year

Enrollment Under the Affordable Care Act Down From ...

In most states, Saturday is the sign-up deadline for coverage beginning Jan. 1

Recalled Kotex Tampons Can Unravel Inside Body

Recalled Kotex Tampons Can Unravel Inside Body

Small number of reports include infections, vaginal irritation, localized vaginal injury

FDA: Some E-Cigarette Liquids Contain Erectile Dysfunction Meds

FDA: Some E-Cigarette Liquids Contain Erectile Dysfunction Meds

Sildenafil and tadalafil not approved to be sold over the counter and are being sold illegally

is free, fast, and customized just for you!




Already a member?

Sign In Now »